Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology/Infectious Diseases
Clinical Trials: Rhinitis, Allergic, Perennial
A listing of clinical trials currently looking for volunteers to enroll in Rhinitis, Allergic, Perennial studies. Click on the closest city to find more detailed information on a research study in your area.
Little Rock : Arkansas Pediatric Clinic Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Costa Mesa : West Coast Clinical Trials, LLC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Downey : Premier Health Research Center Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Huntington Beach : Allergy and Asthma Specialists Medical Group Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Los Angeles : Clinica Medica San Miguel Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Mission Veijo : Allergy and Asthma Assoc of Southern CA Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
View More »
Paramount : Center for Clinical Trials, LLC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
San Diego : Allergy and Asthma Medical Group & Research Center Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
San Diego : Allergy Associates Medical Group Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Santa Barbara : Sansum Clinic Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Centennial : IMMUNOe International Research Centers Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Centennial : Colorado Allergy and Asthma Centers, PC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Colorado Springs : Storms Clinical Research Institute Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Pueblo : Ashtma and Allergy Associates Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Lawerenceville : DataQuest Medical Research, LLC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Stockbridge : Atlanta Allergy and Asthma Clinic Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Stockton : Clinical Research Atlanta Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Normal : Sneeze, Wheeze, & Itch Associates, LLC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Iowa City : Iowa Clinical Research Organization Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Lexington : University of Kentucky Chandler Medical Center
Allergic Rhinitis Volunteers Needed for Research Study
View More »
Louisville : Family Allergy and Asthma Research Institute Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Bethesda : Gordon Raphael, MD Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Brockton : Beacon Clinical Research Updated New
Do you suffer from Ragweed Pollen
View More »
North Dartmouth : Northeast Medical Research Associates Inc Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Ypsilanti : Respiratory Medicine Research Institute of Michigan, PLC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Plymouth : Clinical Research Institute Inc Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Bozeman : Clinical Research Group of Montana Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Bellevue : The Asthma and Allergy Center, PC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Boys Town : Boys Town National Research Hospital Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Ocean : Atlantic Research Center LLC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Rockville Center : Island Medical Research P.C. Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Fargo : Catalyst Medical Center Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Cincinnati : Sterling Research Group Ltd Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Cleveland : Senders Pediatrics Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Sylvania : Toledo Center for Clinical Research Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Oklahoma City : Allergy, Asthma & Clinical Research Center Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Gresham : Cyn3rgy Research Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Lake Oswego : Baker Allergy Asthma and Dermatolgy Research Center, LLC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Medford : Clinical Research Institute of Southern Oregon, PC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Portland : Allergy Associates Research Center Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Bethlehem : Valley Clinical Research Center Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Upland : Asthma and Allergy Research Associates Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
North Charleston : National Allergy, Ashtma, and Urticaria Centers of Charleston, PA Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Dallas : Pharmaceutical Research & Consulting, Inc.
Do you have allergies? (all ages)
View More »
Austin : Isis Clinical Research LLC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Austin : Sirius Clinical Research Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Boerne : TTS Research Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Dallas : Pharmaceutical Research and Consulting, Inc. Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
El Paso : Western Sky Medical Research Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Kerrville : Kerrville Research Associates Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
New Braunfels : Central Texas Health Research Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
San Antonio : Southwest Allergy and Asthma Research Center, PA Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
San Antonio : Sylvana Research Associates Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Waco : Allergy and Asthma Research Institute Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Salt Lake City : J. Lewis Research Inc. Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
South Jordan : J. Lewis Research Inc. Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Burke : PI-Coor Clinical Research Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Henrico : Clinical Research Partners, LLC Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Seattle : ASTHMA, Inc. Updated
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Chubu : Reserch site
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Hokuriku : Reserch site
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Kanto : Reserch site
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Kinki : Reserch site
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Kyusyu : Reserch site
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Seongnam-si Gyeonggi-do : GSK Investigational Site
A Post-marketing Surveillance to Monitor the Safety of AVAMYS® NS
Seoul : Seoul National University Hospital
Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis
Madrid :
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
Taipei : Chang Gung Children's Hospital
the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
Taipei : MacKay Memorial Hospital
the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
Taipei : Taipei City Hospital Renai Branch
the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
Xindian : Cardinal Tien Hospital
the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
